By Ventura Research Team 2 min Read
Temple Wearable for ₹85,000 Under Scanner For Claims
Share

Summary:

Deepinder Goyal's ₹85,000 Temple wearable has attracted scrutiny over its BrainFlow technology and health-monitoring claims. The screen-free device tracks physiological signals near the forehead, raising questions about scientific validation, measurement accuracy and the distinction between wellness tracking and medical diagnostics.

Deepinder Goyal’s wearable health-tech device, Temple, has drawn attention for its effort to track physiological signals related to blood flow near the brain. The price of the device is ₹85,000, and it went for pre-orders on November 1, 2026.

But the product has come under scrutiny for whether the science that underlies its measurements is sound and the line between fitness tracking and medical diagnostics.

What Is Temple and How Does Temple Work?

Temple is a small wearable without a screen that sticks to the side of the forehead using an adhesive patch.

Instead of the traditional wrist-worn fitness tracker, the device uses optical sensors near the temple to monitor physiological signals.

Its technology is built on a measurement named BrainFlow, which is intended to monitor changes related to blood circulation.

The device also has an Entropy score, which seeks to give a summary of physiological strain based on signals related to activity, recovery and stress.

Temple’s measurements are designed to enable people to see how the body is transforming as a consequence of the course of everyday activities.

But measuring blood-flow-related signals near the forehead is not the same as directly measuring how much blood reaches the brain.

The distinction has become a major talking point about the product.

What is the temple under attack for?

The controversy is over the scientific evidence to support the capabilities that the device is claiming.

Optical sensors on the skin can detect changes in blood flow in superficial tissues. However, such measurements do not necessarily mean direct assessment of cerebral circulation.

The relationship between external blood flow signals and internal brain activity is an open scientific question.

Temple has marketed the device as a wellness product, not a medical diagnostic tool.

This distinction is important as medical devices may need further testing, clinical validation and regulatory approvals depending on their intended use.

The company said some features are still being researched.

The key question for the consumer is whether the recorded measurements reflect accurately and consistently the physiological processes for which they are designed.

Price, Fundraising & Market Potential

Temple is gunning for the premium wearable technology market.

Its first product is much more expensive than most traditional fitness trackers.

Key FactsData
Price of the device₹85,000
Pre-orders openNovember 1st, 2026
Fundraising reported$54M
Valuation for Fundraising$190 million
Orders reportedOver 62 countries
Expected early deliveriesStart of 2027

The early-access package offers lifetime software access and accessories for wearing the device.

Temple’s February 2026 fundraising valued the business at about $190mn, with subsequent reports indicating talks on a higher valuation.

The company has attracted international interest but has yet to show it can make money in the long run.

What Happens to the Temple?

Wearable technology is moving beyond step counting and heart-rate monitoring to include sleep analysis, recovery tracking and advanced physiological measurements.

This creates opportunities for products that provide meaningful health insights.

But scientific validation will be crucial.

Long term outlook for Temple will be driven by accuracy of measurement, reproducibility, customer adoption and independent research.

Its premium price point may hinder adoption by price sensitive customers and future regulatory requirements may impact product development.

The device is an attempt to create a new category of wear monitoring.

Whether it finds broader acceptance will be a matter of demonstrated usefulness, not just product positioning.

Please enter a valid name.

+91

Please enter a valid mobile number.

Enable WhatsApp notifications

Verify your mobile number

We have sent an OTP to +91 9876543210

The OTP you entered is invalid. Please try again.

0:60s

Resend OTP

Hold tight, we'll reach out to you the moment we're ready.
+91
Offer Banner Trigger
Offer Banner

Open a FREE Demat Account

+91